Advertisement
Table 2 RCTs included in the review
| Author | Publisher | Sponsor | Study size | Duration | Comparator |
|---|---|---|---|---|---|
| Nave et al, 2005 | European Journal of Clinical Pharmacology | ALTANA | 18 | Measurements at 0, 15, 30, 45 and 60 mins | CIC 800 mcg (HFA MDI) od am Vs. BUD 800 mcg (turbohaler) od am |
| Richter et al, 2005 | Journal of Clinical Pharmacology | ALTANA | 18 | Measurements at 0, 15, 30, 45 and 60 mins | CIC 800 mcg (HFA MDI) od am Vs. FP 1000 mcg (HFA MDI) od am |
| Lee, Fardon et al, 2005 | Chest | AVENTIS | 14 | 4 weeks Crossover with 2 week washout period | CIC 800 mcg (HFA MDI) bd Vs. FP 1000 mcg (HFA MDI) bd |
| Lee, Haggart et al, 2004 | British Journal of Clinical Pharmacology | AVENTIS | 19 | 4 weeks Crossover with 2 week washout period | CIC 400 mcg (HFA MDI) od am Vs. FP 250 mcg (HFA MDI) bd |
| Kanniess et al, 2001 | Pulmonary Pharmacology and Therapeutics | None declared | 15 | 2 weeks (Cross over study with at least 3 week washout period) | CIC 400 mcg (HFA MDI) od am Vs. BUD 400 mcg (turbohaler) od am |
